Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03241290
Other study ID # 38RC17.010
Secondary ID 2017-A00103-50
Status Completed
Phase
First received
Last updated
Start date May 29, 2017
Est. completion date January 30, 2019

Study information

Verified date March 2019
Source University Hospital, Grenoble
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

THALES-EVAQUAL study assesses the quality of the images generated by C-ARM ARCO FP-Rk521S and its ability to be used during surgery.


Description:

Expected performance of TED developped technology compared to current equipment (intensifier tube) represent a significant improvement; especially in term of image rendering, irradiation dose reduction and ergonomy.

THALES-EVAQUAL is a prospective,monocentric, unrandomized, and uncontrolled study which objective is to assess C-ARM ARCO FP-Rk521S in term of quality of image. It also evaluates its ability to be used during Orthopedic, neurological and neurological surgeries.

Patient included in the study will have a surgery during which C-ARM is used. This study doesn't modify the medical care of the patient.

After each surgery, a digital scale of image quality will be filled by the surgeon for each aquisition. Other feedback questionnaires regarding the suitability of the device and the satisfaction of the surgeon will also be completed.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date January 30, 2019
Est. primary completion date December 11, 2018
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Subject having signed the non-objection form;

- Requiring one of the following surgical procedures:

- Urology: soft ureteroscopy, uteroscopy, sacral neuromodulation, JJ sent placement.

- Orthopedics: vertebroplasty, gamma nail placement, sacro-iliac screw fixation.

- Neurology: spinal surgery

Exclusion Criteria:

- Subject who refuse to participate in the study;

- Who are under legal protection measure or unable to express their consent (guardianship, curatorship);

- Deprived of liberty by judicial or administrative decision.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
France University Hospital, Grenoble Grenoble

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Grenoble Clinical Investigation Centre for Innovative Technology Network

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Digital scale of image quality Digital scale of image quality completed for each acquisition by the surgeon up to 5 hours
See also
  Status Clinical Trial Phase
Recruiting NCT02798068 - Steroids and Microcirculation In Cardiac Surgery Phase 4
Completed NCT04172662 - Music Therapy as an Adjunct in CIED Lead Extraction Procedures N/A